
https://www.pharmacytimes.org/on-demand/impact-of-von-willebrand-disease-on-costs-and-patient-outcomes-featuring-a-patient-perspective-enduring

https://www.pharmacytimes.org/on-demand/impact-of-von-willebrand-disease-on-costs-and-patient-outcomes-featuring-a-patient-perspective-enduring

Circulating tumor DNA (ctDNA) can be analyzed in patients with cancer to detect minimal residual disease (MRD). Two abstracts, presented at the American Association for Cancer Research Annual Meeting 2019, evaluated ctDNA analysis and ways of tracking MRD.

The April issue of The American Journal of Managed Care® (AJMC®) featured research on deaths in opioid users, colorectal cancer screening, and health system competition. Here are 5 findings from research published in the issue.

Washington is set to become the first state to offer long-term care benefits for those who pay into the program; a genome-wide polygenic score can predict the odds of obesity; and Montana is moving to reauthorize Medicaid expansion with the addition of community engagement requirements.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.


In rare cases, despite being on antiretroviral therapy and being virally suppressed, patients experience extreme immune decline.

Locations in Ohio, Kentucky, New York, and Massachusetts were selected for an opioid abuse prevention and treatment initiatives as part of a multimillion dollar interagency federal research effort, led by the National Institutes of Health.

Shoshana Lipson, a patient advocate and founder of the “ CGRP & Migraine Community ” on Facebook explains how the group works to support patients with migraine.

Heart disease was the number one reason for “excess deaths” after Hurricane Maria struck Puerto Rico in September 2017.

A new immunotherapy approach was found to both expose HIV concealed within CD4+ T cells and kill it, which could potentially lead to an eventual vaccine for the virus.

https://www.pharmacytimes.org/on-demand/the-era-of-parp-inhibition-in-cancer-management-patient-selection-and-deciding-when-to-use-in-treatment-enduring


Dozens of doctors and other medical professionals have been charged with exchanging opioids and other drugs for sex and cash; the first 2 patients in the United States have been treated with CRISPR; doctors have cured infants of immunodeficiency syndrome using gene therapy made from HIV.

When breast cancer spreads, it often goes to the bones, and new research has found that exposure to dim light at night may contribute to this spread. Results from the animal study were presented at ENDO 2019, the annual meeting of the Endocrine Society.

Patients with cystic fibrosis who had cytomegalovirus had earlier times to lung transplant referral and reaching final stages of disease.

In preparation for Every Kid Healthy Week, which kicks off on April 22, WalletHub has released findings from a recent report on 2019’s Best and Worst States for Children's Health Care.

In a review of revefenacin, researchers found that the drug may have the potential to serve as long-acting bronchodilator for once-daily treatment of respiratory disorders such as chronic obstructive pulmonary disease (COPD).

Humana has launched their Oncology Model of Care to improve patient experiences and outcomes for its Medicare Advantage and commercial members being treated for cancer.

Sanjay M. Patel is founder and chief executive officer of Practice Pro, a leading developer of therapy practice management software that helps clients develop more efficient practices, engage effectively with patients and therapists, maximize billing and collections, and access unparalleled insight into their physical therapy practices.

Two Democratic members of Congress introduced a bill this week aimed at reversing the increase in vaping among children and teenagers by raising the minimum purchasing age for all tobacco products to 21 years old, among other things.

A first-of-its-kind law in Tennessee will limit the language lawyers can use in ads seeking to sue drug makers; consumers spend significantly more on healthcare in the week after they get their tax return; New Hampshire has seen 79 new cases of hepatitis A since November.

The scientists used machine learning to test the algorithm and believe it could double the number of women who would be treated with poly (ADP-ribose) polymerase (PARP) inhibitors for breast cancer.

Incidence of nonvertebral fractures significantly decreased as T-scores improved during treatment with denosumab for osteoporosis.

The investment fund spun off from the Multiple Myeloma Research Foundation will start at $50 million and will be self-sustaining, focusing on early-stage biotech companies.

Researchers recently found a 2-way association between onset of fibromyalgia (FM) and that of migraine in patients with migraine and those with FM, respectively.

Health centers in Medicaid expansion states are more likely to report improvements in financial stability, offer medication-assisted treatment for opioid addiction, and coordinate care with social service providers in the community compared with health centers in nonexpansion states.

The FDA creates an advisory list for dietary supplements; researchers in Israel bio-printed a small-scale heart with human tissue and blood vessels; patient advocates lobby to lift a ban on a controversial fertility treatment.

While digital health companies strive to address important healthcare issues by developing products and service offerings in various categories such as genome sequencing, analytics, telemedicine, mobile apps, and population health management tools, little evidence is available in the digital space when it comes to peer-reviewed publications, measurement of potential impact, and effect on patients with the greatest burden of disease, says Meridith Peratikos, Director of Enterprise Research, axialHealthcare.

Among veterans admitted to the hospital for chronic obstructive pulmonary disease (COPD) exacerbation, women were evaluated and treated differently than men prior to hospitalization and had better hospital-associated outcomes.

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
